Attention! Public Notice - Unauthorised fraudulent communications being circulated on behalf of Singh & Singh.Read more →

Who we are at Singh & Singh

Singh & Singh Law Firm LLP is an Indian law firm with years of experience in Intellectual Property Law, Media and Telecommunications Laws, Arbitration, Competition Law, Law of Taxation, and Drugs Regulatory Laws. With a highly qualified and experienced team of legal professionals, the Firm can identify the core of a client's issues to provide suitable solutions. Singh & Singh was founded by Mr. Maninder Singh and Mrs. Prathiba M. Singh.

Singh & Singh, today, is an aggregation of a dynamic team of lawyers and professionals, who are dedicated to protecting and advancing the interests of its clients. The Firm has a team of highly experienced and qualified professionals who have a rich experience in handling intricate and crucial matters.

The Firm has been at the centre of several landmark cases, especially in SEP jurisprudence, pharmaceutical patents, trademark rights, competition law and telecom regulation.

Legal building with columns
Key defining moments

Key defining moments

2012

F. Hoffman La Roche vs Cipla Limited

The ruling balanced patent rights with public interest, initially favoring Cipla to ensure affordable access to life-saving drugs. However, the Supreme Court later upheld Roche's patent, reinforcing India's evolving patent landscape.

Patents
2013

India TV Independent News Service Pvt. Ltd. ORs. vs Yashraj Films Pvt. Ltd.

The case reinforced strict copyright protections in media, affirming that unauthorised use of film clips in news broadcasts constitutes infringement, rejecting the defense of fair use.

Copyright
2013

Novartis AG vs. Union of India

The ruling emphasised that incremental innovations lacking significant therapeutic efficacy do not qualify for patents, strengthening India's stance on affordable medicines. This decision had a global impact on pharmaceutical patents, setting a precedent for access to essential drugs.

Patents
2017

Union Of India vs Pfizer Ltd.

The ruling clarified the balance between public interest and patent protection, reinforcing the state's authority to regulate essential medicines. This case is a key precedent in India's evolving intellectual property and competition law landscape.

Drug regulatory
2017

Toyota Jidosha Kabushiki Kaisha vs M/S Prius Auto Industries Limited

Toyota, the plaintiff, failed to prove that the "Prius" mark had substantial recognition among Indian consumers before the defendant's adoption. The court emphasised the need for actual goodwill and local consumer awareness for trademark protection.

Trademarks
2019

Star India vs Department of Industrial Policy and Promotion

The court addressed crucial issues regarding broadcasting rights and compulsory licensing under the Copyright Act. The ruling clarified the scope of government intervention in licensing arrangements for sports broadcasting. This case significantly impacted the balance between intellectual property rights and public access to sports content.

Telecom & Broadcasting
2024

Monsanto Holdings private Limited & Ors. vs Competition Commission of India and Ors.

The case concerns CCI's investigation into Monsanto for alleged anti-competitive practices in India's Bt cotton seed market. Monsanto challenged CCI's jurisdiction, but the courts upheld the probe, highlighting the balance between intellectual property rights and competition law.

Competition
2024

Telefonaktiebolaget LM Ericsson (PUBL) vs Lava International

This case resolved key issues in India's first post-trial SEP ruling, including patent essentiality, infringement, and FRAND royalty determination. The Delhi High Court found Lava liable for using Ericsson's telecom technology without a FRAND license, awarding INR 244 crores in damages. This landmark decision sets a precedent for SEP enforcement in India.

Patents